Sartorius Stedim Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.10.24	Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 (EQS Group)
18.07.24	Half-year results 2024 of SartoriusStedimBiotech (EQS Group)
18.07.24	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 (EQS Group)
17.05.24	Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast (EQS Group)
18.04.24	Sartorius Stedim Biotech publishes unaudited first quarter results for 2024 (EQS Group)
26.03.24	Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (EQS Group)
16.02.24	Sartorius Stedim Biotech releases Universal Registration Document 2023 (EQS Group)
07.02.24	Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting (EQS Group)
07.02.24	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights (EQS Group)
26.01.24	Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook (EQS Group)
19.10.23	Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech (EQS Group)
12.10.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023 (EQS Group)
21.07.23	Sartorius Stedim Biotech H1 Profit, Orders Down; Backs Weak FY23 Outlook (RTTNews)
21.07.23	Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech (EQS Group)
18.07.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus (EQS Group)
16.06.23	Sartorius Stedim Biotech lowers forecast for 2023 (EQS Group)
20.04.23	Sartorius Stedim Biotech Q1 Profit Declines, Sales Revenue Down 18.4% Organically; Confirms Outlook (RTTNews)
20.04.23	Sartorius Stedim Biotech SA: First-quarter results 2023 of Sartorius Stedim Biotech (EQS Group)
31.03.23	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus (EQS Group)
27.03.23	Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board (EQS Group)
08.02.23	Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders Meeting (EQS Group)
26.01.23	Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View (RTTNews)
19.10.22	Nine-month results 2022 of Sartorius Stedim Biotech (PR Newswire)
08.08.22	Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions (PR Newswire)
21.07.22	Sartorius Stedim Biotech H1 Profit Climbs; Confirms FY22 Outlook - Quick Facts (RTTNews)
21.07.22	Half-year results 2022 of Sartorius Stedim Biotech (PR Newswire)
21.04.22	Sartorius records dynamic start to the new fiscal year (PR Newswire)
21.04.22	First-quarter results 2022 of Sartorius Stedim Biotech (PR Newswire)
29.03.22	Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A. (PR Newswire)
17.02.22	Sartorius Stedim Biotech presents annual report for 2021 (PR Newswire)
09.02.22	Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 1.26 euros per share to Annual Shareholders' Meeting (PR Newswire)
08.02.22	Sartorius Stedim Biotech completes acquisition of Novasep's chromatography division (PR Newswire)
27.01.22	Preliminary results 2021 of Sartorius Stedim Biotech (PR Newswire)
20.10.21	Nine-month results of Sartorius Stedim Biotech (PR Newswire)
29.07.21	Sartorius Stedim Biotech acquires cell culture specialist Xell AG (PR Newswire)
21.07.21	Half-year results of Sartorius Stedim Biotech (PR Newswire)
21.07.21	Résultats semestriels de Sartorius Stedim Biotech (PR Newswire)
06.07.21	Sartorius Stedim Biotech Sees H1 Revenue Growth 61% In CC (RTTNews)
05.07.21	Sartorius Stedim Biotech provides preliminary first-half financial key figures and raises forecast for 2021 (PR Newswire)
05.07.21	Sartorius Stedim Biotech communique sur ses chiffres clés préliminaires pour le premier semestre 2021 et relève ses prévisions pour l'ensemble de l'exercice (PR Newswire)
02.07.21	Sartorius Stedim Biotech strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix (PR Newswire)
02.07.21	Sartorius Stedim Biotech renforce son portefeuille de produits pour les thérapies géniques et cellulaires en acquérant une participation majoritaire dans CellGenix (PR Newswire)
21.04.21	Sartorius Stedim Biotech Q1 Profit, Order Climb; Backs FY21, Mid-range Targets (RTTNews)
21.04.21	First-quarter results of Sartorius Stedim Biotech (PR Newswire)
21.04.21	Résultats de Sartorius Stedim Biotech pour le premier trimestre (PR Newswire)
24.03.21	Résolutions de l'Assemblée générale annuelle mixte de Sartorius Stedim Biotech S.A. (PR Newswire)
24.03.21	Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A. (PR Newswire)
18.03.21	Sartorius Stedim Biotech Lifts FY21 Outlook; Stock Up (RTTNews)
18.03.21	Sartorius Stedim Biotech augmente ses prévisions pour l'ensemble de l'année 2021 (PR Newswire)
18.03.21	Sartorius Stedim Biotech increases its full-year 2021 guidance (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	71.82	2.51 %	K V
UBS Group	28.00	1.19 %	K V
Part Grp Hldg	1’267.00	1.04 %	K V
Lonza Grp	522.00	0.97 %	K V
Swiss Re	129.65	0.74 %	K V
Roche Hldg G	252.60	0.04 %	K V
Nestle	76.22	-0.18 %	K V
Sonova Hldg	302.90	-0.36 %	K V
CieFinRichemont	121.15	-0.62 %	K V
Givaudan	3’847.00	-0.85 %	K V

Nachrichten zu Sartorius Stedim Biotech

Aktien Top/Flop

Sartorius Stedim Biotech Peer Group Nachrichten

Meistgelesene Nachrichten